In September 2015, the Philanthropy Advisory Service released "Small Cell Lung Cancer: A Giving Smarter Guide to Accelerating Research Progress." The report outlines the key barriers to small cell lung cancer research progress and pinpoints research solutions that will help philanthropists make strategic investments.
"Philanthropy is far more than just writing checks. It takes an entrepreneurial approach that seeks out best practices and empowers people to change the world."
MICHAEL MILKEN, CHAIRMAN AND FOUNDER, FASTERCURES
THE NEED IS GREAT
Consider that with more than 10,000 known diseases affecting our world today, there are treatments available for 500 of them. Less than half of these diseases have dedicated research groups focused on accelerating their cures.
We need to deploy smarter giving strategies to invest in high-risk biomedical research to yield high-reward and have a significant impact on medical innovation. PAS educates stakeholders about how informed, measurable giving can improve medical research.
Though it only accounts for 3% of overall U.S. spending on medical research, its nimble, collaborative, and results-driven approach is transforming the system.
The Philanthropy Advisory Service (PAS) counsels philanthropists, family offices, wealth advisors, and foundations seeking to make transformative investments in medical research.
We provide comprehensive, digestible information that helps philanthropists evaluate research efforts and funding opportunities in various disease areas. Scientific advisory boards, in-depth due diligence, and an objective framework for evaluation shape our analysis. Contact PAS to start giving smarter.